Press Release· November 2, 2026
Nuvation Bio to Present Additional Updated Phase 2 Results at 2026 Society for Neuro-Oncology Annual Meeting
Source: Nuvation Bio Inc.#Press Release
Topic
Press Release
Press releases from companies and organisations, preserving the original publication date, issuing organisation and source announcement.
66 articles·Last updated
Press Release· November 2, 2026
Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resistant Breast Cancer Models
Source: Actinium Pharmaceuticals, Inc.#Press Release
Press Release· November 2, 2026
ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
Source: ADC Therapeutics SA#Press Release
Press Release· November 2, 2026
Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future
Source: Karyopharm Therapeutics Inc.#Press Release
Press Release· November 2, 2026
Protego to Highlight PROT-001's Potential to Target Light Chain Toxicity in AL Amyloidosis at ISA 2026
Source: Protego Biopharma#Press Release
Press Release· November 2, 2026
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
Source: OncoC4#Press Release
Press Release· November 2, 2026
Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium
Source: Kazia Therapeutics Limited#Press Release
Press Release· November 2, 2026
Keenova Therapeutics to Report Third Quarter 2026 Financial Results on November 10, 2026
Source: Keenova Therapeutics#Press Release
Press Release· November 2, 2026
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
Source: RedHill Biopharma Ltd.#Press Release